Latest News

 Filter by Provider

Harmony Biosciences (NASDAQ:HRMY) highlighted record quarterly performance for its narcolepsy treatment WAKIX and outlined development plans across its orexin, epilepsy and pitolisant lifecycle-management programs during Piper Sandler’s virtual CNS Symposium. Peter Anastasiou, the company’s chief o

Gemini Space Station (NASDAQ:GEMI) reported second-quarter revenue growth despite weaker crypto trading activity, as expanding services revenue, over-the-counter trading and new product offerings offset a decline in exchange revenue. The company also highlighted lower operating costs following restr

ImmuCell (NASDAQ:ICCC) reported higher second-quarter sales and earnings as domestic demand for its calf scours prevention products increased, while the company outlined plans to invest about $8 million to more than triple manufacturing capacity by the end of 2027. Product sales rose 11.5% year ove

Digi Power X (NASDAQ:DGXX) reported second-quarter revenue of $6.6 million as it continued shifting from legacy operations toward artificial intelligence computing, colocation and GPU rental services. The company also recorded its first revenue from GPU bare-metal rentals and reported positive adjus

Stratec (ETR:SBS) said its second-quarter performance improved significantly from a weak start to 2026, helping narrow its year-on-year sales and earnings gap in the first half. The company maintained its full-year guidance despite lower demand for service parts and consumables and an expectation th

AirJoule Technologies (NASDAQ:AIRJ) said its second-quarter efforts centered on expanding commercial channels for its atmospheric water-generation and dehumidification systems, including an exclusive residential-development sales agreement with Kubota Corp. and planned deployments in the United Stat

Investors are overestimating Meta's AI moat as the industry shifts from compute-driven scaling to algorithmic innovation, Ben Goertzel says.

Michael Burry added to AI shorts in Oracle, Micron and Nebius as he warned excess compute capacity could hit the market by 2028.

A 26-year-old earning $100,000 a year found himself facing a question many ambitious young professionals eventually encounter: Is working hard worth it, or is he missing out on life? Kyle from New York City brought

APi Group (NYSE:APG) has outperformed the market over the past 5 years by 12.03% on an annualized basis producing an average annual return of 23.91%. Currently, APi Group has a market capitalization of $18.90 billion.

This Canadian dividend stock pays 8.2% and sends cash to your account every single month. Here's why Atrium MIC deserves a look.

Record backlog of $3.36 billion and data center expansion drive guidance raise.

Surgeon adoption of new bunion systems drove accelerating case volume growth.

September Fed hike odds have plunged. Here’s why stocks are benefiting while long-term Treasury yields may stay elevated.

Specialty products drove $175.2M adjusted EBITDA amid SAF expansion plans.

Choosing a suitable Reddy Anna White Label Panel Provider requires careful research because every provider may offer different features, technology standar

Dell Technologies stock has room to run after its recent breakout, according to a Wells Fargo Securities analyst.

OTT revenue returned to growth for first time since 2024.

Jual Obat Aborsi Asli 081466799220 Obat Penggugur Kandungan, Obat Cytotec Misoprostol, Obat Gastrul, Obat Pendorong Janin, Obat Terlambat Datang Bulan, Car

Resideo beat sales and earnings expectations in fiscal Q2, but that hasn't stopped the stock from getting hit with big sell-offs.

Curaleaf's unsolicited $272 million tender offer for Aurora Cannabis targets EU-GMP cultivation capacity, with Aurora's board forming a special committee to evaluate the cash-and-stock bid.

Should you give up on Meta Platforms?

BayFirst Financial (NASDAQ:BAFN) held its second-quarter earnings conference call on Friday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial data and

Mark Cuban is urging funds to divest from major health insurers. Here’s how broad-market ETFs remain exposed to the companies he’s targeting.

CEO Sims discusses price increases, Eastover expansion, and European margin challenges.

Red Cat stock rose as new U.S. tariffs on imported drones boost domestic manufacturers like RCAT. Find out what this means for investors.

Revenue grew 13% as MTL integration and Polish market strength drove results.

Political ad revenue surged past forecasts amid turbulent macro conditions.

Fishing and diving segments drive 5% sales growth despite tariff refund boost to margins.

Revenue climbed 6.6% while adjusted EBITDA hit a 13-quarter high.

Pricing gains offset $72M in raw material inflation as nylon sales surged 26%.

Firy (NYSE:FIRY) reported second-quarter financial results on Friday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga APIs. For

US stocks mixed, Nasdaq up 0.2%. Retail sales down 0.6% in July. Wetour Robotics up 150%, while Innventure Inc drops 47%.

Boost Run shares rally after strong Q2 results and a GPU infrastructure deal expanding capacity to 111 MW across multiple sites.

Claiming early or waiting until you reach this age before filing for benefits can make a measurable difference in the size of your monthly payment.

Your spreadsheet worked fine when you had fifty SKUs and one warehouse. Then you added a second location, a wholesale channel, and a hundred more products.

On Friday, Lument Finance Trust (NYSE:LFT) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensive

On Friday, Gemini Space Station (NASDAQ:GEMI) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensive

On Friday, Xcel Brands (NASDAQ:XELB) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For real-time access

Dowlais acquisition drives $70M synergy run rate toward $300M three-year target.

New leadership outlines turnaround strategy amid traffic declines and margin pressure.

Moore's indirect sale through Moore Family Trust reduced his equity stake by 10%, leaving him with 26,900 shares valued at $5.64 million.

Celestica is already profiting from today’s AI data-centre buildout, while POET is a high-upside bet that still has to prove mass production.

On Friday, VolitionRX (AMEX:VNRX) discussed second-quarter financial results during its earnings call. The full transcript is provided below. Benzinga APIs provide real-time access to earnings call transcripts and

Logistical constraints and weak steel demand pressured second-quarter results.

Koch Filter integration on track as net sales hit $528 million.

Fiber expansion accelerates as spectrum monetization strengthens balance sheet.

Aviation leasing scaled as revenue surged 110% and sand margins turned positive.

Healthcare billings surged 19% as automation drives margin expansion.

Redomicile to Delaware and rate recovery wins across multiple state jurisdictions.